These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 488357)

  • 1. A structural requirement for the conversion of prostaglandin endoperoxides to thromboxanes.
    Diczfalusy U; Hammarström S
    FEBS Lett; 1979 Sep; 105(2):291-5. PubMed ID: 488357
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetic studies on the conversion of prostaglandin endoperoxide PGH2 by thromboxane synthase.
    Anderson MW; Crutchley DJ; Tainer BE; Eling TE
    Prostaglandins; 1978 Oct; 16(4):563-70. PubMed ID: 725086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of prostaglandin endoperoxides to C17-hydroxy acids catalyzed by human platelet thromboxane synthase.
    Diczfalusy U; Falardeau P; Hammarström S
    FEBS Lett; 1977 Dec; 84(2):271-4. PubMed ID: 598509
    [No Abstract]   [Full Text] [Related]  

  • 4. Thromboxane A2 and prostaglandin H2 form covalently linked derivatives with human serum albumin.
    Maclouf J; Kindahl H; Granström E; Samuelsson B
    Adv Prostaglandin Thromboxane Res; 1980; 6():283-6. PubMed ID: 7386268
    [No Abstract]   [Full Text] [Related]  

  • 5. Interactions of prostaglandin H2 and thromboxane A2 with human serum albumin.
    Maclouf J; Kindahl H; Granström E; Samuelsson B
    Eur J Biochem; 1980 Aug; 109(2):561-6. PubMed ID: 7408901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Kinetic mechanisms of enzyme activity of the thromboxane synthetase system. Thromboxane synthetase of human platelets].
    Basevich VV; Mevkh AT; Varfolomeev SD
    Biokhimiia; 1984 Sep; 49(9):1538-45. PubMed ID: 6440597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the thromboxane synthesizing system in human platelet microsomes.
    Tai HH; Yuan B
    Biochim Biophys Acta; 1978 Dec; 531(3):286-94. PubMed ID: 737191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet rich plasma transforms exogenous prostaglandin endoperoxide H2 into thromboxane A2.
    Fitzpatrick FA; Gorman RR
    Prostaglandins; 1977 Nov; 14(5):881-9. PubMed ID: 594390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of prostaglandin endoperoxide thromboxane isomerase by 1-carboxyalkylimidazoles.
    Yoshimoto T; Yamamoto S; Hayaishi O
    Prostaglandins; 1978 Oct; 16(4):529-40. PubMed ID: 725083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin biosynthesis in platelets: demonstration and role of prostaglandin H2 leads to E2 isomerase.
    Raz A; Aharony D
    Res Commun Chem Pathol Pharmacol; 1978 Sep; 21(3):507-15. PubMed ID: 705027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboxane formation from arachidonic acid and prostaglandin H2 in rabbit spleen.
    Hidaka T; Ueta T; Ogura R
    J Biochem; 1983 Feb; 93(2):367-73. PubMed ID: 6404897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A selective thromboxane synthetase inhibitor blocks the cAMP lowering activity of PGH2.
    Gorman RR; Fitzpatrick FA; Miller OV
    Biochem Biophys Res Commun; 1977 Nov; 79(1):305-13. PubMed ID: 200243
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis of thromboxane B2 in incubates of dog platelet-rich plasma with arachidonic acid and its inhibition by different drugs.
    Chignard M; Vargaftig BB; Sors H; Dray F
    Biochem Biophys Res Commun; 1978 Dec; 85(4):1631-9. PubMed ID: 743319
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet membranes, eicosanoid biosynthesis and putative endogenous calcium ionophores.
    Carey F; Menashi S; Authi KS; Hack N; Lagarde M; Crawford N
    Adv Exp Med Biol; 1985; 192():185-99. PubMed ID: 2422885
    [No Abstract]   [Full Text] [Related]  

  • 15. From studies of biochemical mechanism to novel biological mediators: prostaglandin endoperoxides, thromboxanes, and leukotrienes. Nobel Lecture, 8 December 1982.
    Samuelsson B
    Biosci Rep; 1983 Sep; 3(9):791-813. PubMed ID: 6315101
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibitors of thromboxane synthase in human platelets.
    Alusy UD; Hammarström S
    FEBS Lett; 1977 Oct; 82(1):107-10. PubMed ID: 913565
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of methyl mercury on platelets: induction of aggregation and release via activation of the prostaglandin synthesis pathway.
    Macfarlane DE
    Mol Pharmacol; 1981 May; 19(3):470-6. PubMed ID: 7266471
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of an inhibitor of TXA2 synthesis and of PGE2 on the formation of 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets.
    Vincent JE; Zijlstra FJ; van Vliet H
    Adv Prostaglandin Thromboxane Res; 1980; 6():463-6. PubMed ID: 7386279
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased thromboxane B2 biosynthesis in platelets.
    Kawaguchi H; Ishibashi T; Imai Y
    Lipids; 1982 Sep; 17(9):577-84. PubMed ID: 6815401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
    Hornberger WB; Patscheke H
    Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.